Acquiring Company
Clayton Dubilier & Rice
Acquired Company
Opella (Sanofi's consumer healthcare division)
New York
FranceFinancial ServicesFinanceInvestment ManagementManufacturingHealth CareDescription
The private equity firm Clayton, Dubilier & Rice (CD&R) has entered into exclusive negotiations to acquire a 50-percent stake in Opella, the consumer healthcare division of Sanofi. The French government has put in place stringent requirements to ensure the maintenance of Opella's essential facilities, research operations, and French workforce, as well as the sourcing of key materials from French manufacturers.
Quick answer
Clayton Dubilier & Rice is acquiring Opella (Sanofi's consumer healthcare division), announced October 24, 2024. Clayton Dubilier & Rice is based in New York, New York, United States.
- How much did Clayton Dubilier & Rice pay for Opella (Sanofi's consumer healthcare division)?
- The deal value was not disclosed.
- What does Clayton Dubilier & Rice do?
- Clayton, Dubilier & Rice is a private investment firm with a strategy predicated on building stronger, more profitable businesses.
- Where are Clayton Dubilier & Rice and Opella (Sanofi's consumer healthcare division) based?
- Clayton Dubilier & Rice is based in New York, New York, United States. Opella (Sanofi's consumer healthcare division) is based in France.
- Who are the decision-makers at Clayton Dubilier & Rice?
- Fundz holds 2 contacts at Clayton Dubilier & Rice. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Financial Services and Finance
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- TowerBrook Capital Partners and CD&R complete acquisition of R1 RCM Inc (November 19, 2024)
- Beneficient to acquire Mercantile Bank International Corp. for $1.5 million to expand the range of services, $1.5M (December 5, 2024)
- Beneficient to acquire Mercantile Bank International Corp. to expand alternative asset custody services (December 5, 2024)
- Intermex acquires key assets and operations of Amigo Paisano, S.A. to expand Central American presence (December 4, 2024)
- Astorg completes take-private of Hamilton Thorne and acquires Cook Medical Reproductive Health (December 2, 2024)
- Mirae Asset Financial Group completes acquisition of Sharekhan to expand its presence in the Indian market (November 28, 2024)
Who to call at Clayton Dubilier & Rice, and when
When Clayton Dubilier & Rice changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Clayton Dubilier & Rice raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Clayton Dubilier & Rice, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Clayton Dubilier & Rice. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Clayton Dubilier & Rice makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Opella (Sanofi's consumer healthcare division)?
Opella (Sanofi's consumer healthcare division) was acquired by Clayton Dubilier & Rice, based in New York. The deal was reported on October 24, 2024. Clayton, Dubilier & Rice is a private investment firm with a strategy predicated on building stronger, more profitable businesses. Clayton Dubilier & Rice is privately held and operates in Financial Services.
When did Clayton Dubilier & Rice acquire Opella (Sanofi's consumer healthcare division)?
Clayton Dubilier & Rice's acquisition of Opella (Sanofi's consumer healthcare division) was reported on October 24, 2024. The private equity firm Clayton, Dubilier & Rice (CD&R) has entered into exclusive negotiations to acquire a 50-percent stake in Opella, the consumer healthcare division of Sanofi. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Opella (Sanofi's consumer healthcare division) do?
Opella, a consumer healthcare division of Sanofi, is responsible for manufacturing popular over-the-counter products such as Doliprane painkillers, Dulcolax laxatives, and various medicines and vitamins. It is privately held, operating in Manufacturing, and is based in France.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.